Recurrent Stroke Associated with Cannabis Use
JNNP 76:435-437, Mateo,I.,et al, 2005
Blood Pressure Control and Risk of Stroke
Stroke 36:725-730, Li,C.,et al, 2005
Neurologic and Developmental Disability at Six Years of Age After Extremely Preterm Birth
NEJM 352:9-19, 71, Marlow,N.,et al, 2005
Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005
Prognostic Significance of Admission Levels of Troponin I in Patients With Acute Ischaemic Stroke
JNNP 76:76-81, Di Angelantonio,E.,et al, 2005
Expanding Indications for Statins in Cerebral Ischemia
Arch Neurol 62:67-72,23, Ovbiagele,B.,et al, 2005
Bone Mineral Density and the Risk of Alzheimer Disease
Arch Neurol 62:107-111, Tan,Z.S.,et al, 2005
A 32-Year Prospective Study of Change in Body Weight and Incident Dementia
Arch Neurol 62:55-60,20, Stewart,R.,et al, 2005
Risk Factors for Stroke in Subjects With Normal Blood Pressure
Stroke 36:234-238, Li,C., et al, 2005
Outdoor Air Pollution and Stroke in Sheffield, United Kingdom
Stroke 36:239-243, Maheswaran, R., et al, 2005
Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in Elderly Patients With Stroke (C-PEPS, M-PEPS, L-PEPS)
Stroke 36:259-263, Ngeh, J. & Goodbourn, C., 2005
Vascular Risk Factors and Diabetic Neuropathy
NEJM 352: 341-350, 408, Tesfaye, S., et al, 2005
A Fatal Encephalitis
Lancet 365:358, Schankin, C.J., et al, 2005
A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations
Arch Neurol 62:241-248, The PRESTO Study, 2005
Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke 36:583-587, Naidech,A., et al, 2005
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 352: 777-785, 828, Mayer, S.A., et al, 2005
Risk of Ischaemic Stroke in People With Migraine: Systemic Review and Meta-analysis of Observational Studies
BMJ 330:63-65, 54, Etminan,M.,et al, 2005
Homocysteine and Stroke: Evidence on a Causal Link From Mendelian Randomisation
Lancet 365:224-232, 194, Casas, J.P., et al, 2005
Association Between Hormone Replacement Therapy and Subsequent Stroke: A Meta-analysis
BMJ 330:342-345, Bath, P.M.W. & Gray, L.J., 2005
Timing of TIAs Preceding Stroke
Neurol 64:817-820, Rothwell, P.M. & Warlow, C.P., 2005
Atypical Antipsychotic Drugs and Risk of Ischaemic Stroke: Population Based Retrospective Cohort Study
BMJ 330:445-448, Gill,S.S., et al, 2005
The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005
Lamotrigine and the Risk of Malformations in Pregnancy
Neurol 64:955-960, 938, Cunnington, M. , et al, 2005
Rasagiline as an Adjunct to Levodopa in Patients With Parkinsons Disease and Motor Fluctuations (LARGO, Lasting Effect in Adjunct Therapy With Rasagiline Given Once Daily, Study)
Lancet 365:947-954, 914, Rascol,O., et al, 2005
Clinical Study of 99 Patients with Pure Sensory Stroke
J Neurol 252:156-162, Arboix, A.,et al, 2005
Unusual Presentation of Neurocysticercosis: Report of Two Cases
Nepal Journal of Neuroscience 2:185-189, Gurung,G.,et al, 2005
Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005
Treatment and Prevention of Primary Intracerebral Hemorrhage
Semin Neurol 25:445-452, Towfighi,A.,et al, 2005
Frequency and Clinical Predictors of Adverse Reactions to Chiropractic Care in the UCLA Neck Pain Study
Spine 30:1477-1484, Hurwitz,E.L.,et al, 2005
Posterior Cerebral Artery Stroke
e medicine, Hill,M.D., 2005
Underappreciated Statin-Induced Myopathic Weakness Causes Disability
Neurorehabil Neural Repair 19:259-263, Dobkin,B.H., 2005
Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome After Intra-Arterial Reperfusion Therapy
AJNR 26:1798-1803, Schwamm,L.,et al, 2005
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Clin Inf Dis 41:634-653, Roden, M.M.,et al, 2005
Neurocysticercosis: Updated Concepts about an Old Disease
Lancet Neurol 4:653-661, Garcia, H.H.,et al, 2005
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
NEJM 351:2611-2618, Smeeth,L.,et al, 2004
Migraine and Other Headaches
Neurol 63:2233-2239,2209, Rose,K.M.,et al, 2004
Hyperhomocysteinemia, Low Folate and Vitamin B12 Concentrations, and Methylene Tetrahydrofolate Reductase Mutation in Cerebral Venous Thrombosis
Stroke 35:1790-1794, Cantu,C.,et al, 2004
Multiple Cerebral Microbleeds:MRI Marker of a Diffuse Hemorrhage-Prone State
J Neuroimaging 14:54-57, Chalela,J.A.,et al, 2004
Clinicopath Conf., Leprosy
NEJM 350:166-176, Case 1-2004, 2004
Acquired Immunodeficiency Syndrome and the Risk of Stroke
Stroke 35:51-56, Cole,J.W.,et al, 2004
Transmissible Spongiform Encephalopathies
Lancet 363:51-61, Collins,S.J.,et al, 2004
Tapeworms and Seizures--Treatment and Prevention
NEJM 350:215-217, Maguire,J.H., 2004
Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements
Arch Neurol 61:82-88, Zandi,P.P.,et al, 2004
Bovine Spongiform Encephalopathy in the United States - An Epidemiologist's View
NEJM 350:539-542, Donnelly,C.A., 2004
Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
JAMA 291:565-575,621, Toole,J.F.,et al, 2004
Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients with Ischemic Stroke
JAMA 291:576-584, The APASS Investigators, 2004
Migraine as a Risk Factor for Subclinical Brain Lesions
JAMA 291:427-434, Kruit,M.C.,et al, 2004
Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004
Recipients of Blood or Blood Products "at vCJD risk"
BMJ 328:118-119, Bird,S.M., 2004
Vertebrobasilar Dolichoectasia Diagnosed by Magnetic Resonance Angiography and Risk of Stroke and Death:A Cohort Study
JNNP 75:22-26, Ubogu,E.E.&Zaidat,O.O., 2004